|
Volumn 13, Issue 74, 2004, Pages 203-206
|
Sustained-release methylphenidate. New pharmaceutical forms: A slight advantage for a small number of children
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHETAMINE DERIVATIVE;
ANESTHETIC AGENT;
ANTICONVULSIVE AGENT;
COUMARIN;
METHYLPHENIDATE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
CENTRAL STIMULANT AGENT;
ABDOMINAL PAIN;
AGGRESSIVENESS;
ANOREXIA;
ARTICLE;
ATTENTION DEFICIT DISORDER;
AUDITORY HALLUCINATION;
CAPSULE FILLING;
CARDIOVASCULAR DISEASE;
CHILD;
CHILD CARE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG DOSAGE FORM;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG GRANULE;
DRUG MARKETING;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG OVERDOSE;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FRANCE;
HEADACHE;
HUMAN;
HYPERTENSION;
INHIBITION KINETICS;
INSOMNIA;
INTERMETHOD COMPARISON;
INTESTINE OBSTRUCTION;
MEDICATION ERROR;
META ANALYSIS;
OUTCOMES RESEARCH;
RATING SCALE;
RISK ASSESSMENT;
SENSITIVITY ANALYSIS;
SIDE EFFECT;
SINGLE DRUG DOSE;
SUSTAINED RELEASE FORMULATION;
SWALLOWING;
SYSTEMATIC REVIEW;
TABLET FORMULATION;
TIC;
VOMITING;
CHILD BEHAVIOR;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DELAYED RELEASE FORMULATION;
DRUG ADMINISTRATION;
DRUG APPROVAL;
DRUG EFFECT;
MICROCAPSULE;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT OUTCOME;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CAPSULES;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
CHILD BEHAVIOR;
CLINICAL TRIALS;
CROSS-OVER STUDIES;
DELAYED-ACTION PREPARATIONS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG APPROVAL;
FRANCE;
HUMANS;
METHYLPHENIDATE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 16544381562
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (14)
|